Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Truist Financial Co. 

SI-BONE Inc diskutieren

SI-BONE Inc

WKN: A2N7LY / Symbol: SIBN / Name: SI-BONE / Aktie / Ausrüstung & Versorgung / Small Cap /

14,10 €
-1,40 %

Einschätzung Buy
Rendite (%) -14,21 %
Kursziel 24,47
Veränderung
Endet am 28.02.24

SI-BONE, Inc. (NASDAQ: SIBN) had its price target raised by analysts at Truist Financial Co. from $21.00 to $26.00. They now have a "buy" rating on the stock.
Ratings data for SIBN provided by MarketBeat

Einschätzung Buy
Rendite (%) -26,94 %
Kursziel 29,24
Veränderung
Endet am 08.08.24

SI-BONE, Inc. (NASDAQ: SIBN) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $32.00 price target on the stock.
Ratings data for SIBN provided by MarketBeat

Einschätzung Buy
Rendite (%) -26,94 %
Kursziel 28,30
Veränderung
Endet am 08.08.24

SI-BONE, Inc. (NASDAQ: SIBN) had its price target lowered by analysts at Truist Financial Co. from $33.00 to $31.00. They now have a "buy" rating on the stock.
Ratings data for SIBN provided by MarketBeat

Einschätzung Buy
Rendite (%) -26,94 %
Kursziel 27,20
Veränderung
Endet am 10.08.24

SI-BONE, Inc. (NASDAQ: SIBN) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $30.00 price target on the stock.
Ratings data for SIBN provided by MarketBeat

Einschätzung Buy
Rendite (%) -26,94 %
Kursziel 27,76
Veränderung
Endet am 23.08.24

SI-BONE, Inc. (NASDAQ: SIBN) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $30.00 price target on the stock.
Ratings data for SIBN provided by MarketBeat

Einschätzung Buy
Rendite (%) -26,94 %
Kursziel 28,37
Veränderung
Endet am 26.09.24

SI-BONE, Inc. (NASDAQ: SIBN) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $30.00 price target on the stock.
Ratings data for SIBN provided by MarketBeat

Einschätzung Buy
Rendite (%) -10,76 %
Kursziel 23,41
Veränderung
Endet am 07.11.24

SI-BONE, Inc. (NASDAQ: SIBN) had its price target lowered by analysts at Needham & Company LLC from $32.00 to $25.00. They now have a "buy" rating on the stock.
Ratings data for SIBN provided by MarketBeat

Einschätzung Buy
Rendite (%) -10,76 %
Kursziel 23,42
Veränderung
Endet am 07.11.24

SI-BONE, Inc. (NASDAQ: SIBN) had its price target lowered by analysts at Morgan Stanley from $30.00 to $25.00. They now have an "overweight" rating on the stock.
Ratings data for SIBN provided by MarketBeat

Einschätzung Buy
Rendite (%) -10,76 %
Kursziel 23,41
Veränderung
Endet am 07.11.24

SI-BONE, Inc. (NASDAQ: SIBN) had its price target lowered by analysts at Cantor Fitzgerald from $30.00 to $25.00. They now have an "overweight" rating on the stock.
Ratings data for SIBN provided by MarketBeat

Einschätzung Buy
Rendite (%) -17,54 %
Kursziel 23,03
Veränderung
Endet am 04.12.24

SI-BONE, Inc. (NASDAQ: SIBN) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $25.00 price target on the stock.
Ratings data for SIBN provided by MarketBeat

Einschätzung Buy
Rendite (%) -25,79 %
Kursziel 23,59
Veränderung
Endet am 22.12.24

SI-BONE, Inc. (NASDAQ: SIBN) had its price target raised by analysts at Truist Financial Co. from $25.00 to $26.00. They now have a "buy" rating on the stock.
Ratings data for SIBN provided by MarketBeat

Einschätzung Buy
Rendite (%) -11,73 %
Kursziel 22,13
Veränderung
Endet am 27.02.25

SI-BONE, Inc. (NASDAQ: SIBN) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $24.00 price target on the stock, down previously from $26.00.
Ratings data for SIBN provided by MarketBeat

Einschätzung Buy
Rendite (%) -12,80 %
Kursziel 23,06
Veränderung
Endet am 27.02.25

SI-BONE, Inc. (NASDAQ: SIBN) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $25.00 price target on the stock.
Ratings data for SIBN provided by MarketBeat

Einschätzung Buy
Rendite (%) -12,80 %
Kursziel 23,95
Veränderung
Endet am 27.02.25

SI-BONE, Inc. (NASDAQ: SIBN) had its price target raised by analysts at Morgan Stanley from $25.00 to $26.00. They now have an "overweight" rating on the stock.
Ratings data for SIBN provided by MarketBeat

Einschätzung Buy
Rendite (%) -7,84 %
Kursziel 23,11
Veränderung
Endet am 28.03.25

SI-BONE, Inc. (NASDAQ: SIBN) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $25.00 price target on the stock.
Ratings data for SIBN provided by MarketBeat

Einschätzung Buy
Rendite (%) -2,08 %
Kursziel 24,93
Veränderung
Endet am 03.04.25

SI-BONE, Inc. (NASDAQ: SIBN) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $27.00 price target on the stock.
Ratings data for SIBN provided by MarketBeat

Einschätzung Buy
Rendite (%) 6,82 %
Kursziel 25,05
Veränderung
Endet am 07.05.25

SI-BONE, Inc. (NASDAQ: SIBN) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $27.00 price target on the stock.
Ratings data for SIBN provided by MarketBeat

Einschätzung Buy
Rendite (%) -1,40 %
Kursziel 23,23
Veränderung
Endet am 07.05.25

SI-BONE, Inc. (NASDAQ: SIBN) had its price target lowered by analysts at Morgan Stanley from $26.00 to $25.00. They now have an "overweight" rating on the stock.
Ratings data for SIBN provided by MarketBeat